The efficacy of heparin therapy after subcutaneous injection of Common Brown Snake (Pseudonaja textilis) venom was studied in anaesthetised, mechanically ventilated dogs. Intravenous heparin (lOO V/kg), administered fifteen minutes after envenomation, neither prevented nor hastened the recovery from cardiovascular depression and coagulopathy observed after venom administration. Heparin therapy is not recommended for the treatment of established human envenomation.
The venom of Pseudonaja species contains a procoagulant agent, prothrombin activator, which causes disseminated intravascular coagulation and a subsequent hypocoagulable state. In contrast, heparin, which prevents thrombin converting fibrinogen to fibrin by facilitating the action of antithrombin Ill, has an anticoagulant action. The administration of heparin before prothrombin activator prevents the occurrence of disseminated intravascular coagulation. I It has been suggested that heparin may have a role in clinical management of snake-bite. 2 Indeed, it has been utilized in the clinical treatment of coagulopathy following snake-bite 3 ,4 but its efficacy has not been demonstrated.
The aim of this study was to determine the efficacy of heparin therapy in the treatment of established coagulopathy and coagulopathyinduced cardiovascular abnormalities following Pseudonaja envenomation.
MATERIALS AND METHODS Eight dogs were anaesthetised, mechanically ventilated and monitored as described previously. 5 Stroke volume and peripheral vascular resistance were calculated. Blood samples were withdrawn before and after envenomation at specified times for full blood examinations, serum fibrinogen levels, prothrombin times, activated partial thromboplastin times and cross-linked fibrin degradation products. Heart rate, blood pressure, central venous pressure and cardiac output were recorded in triplicate and averaged. The electrocardiograph was monitored continuously, Pseudonaja textilis venom in a dose of 140-160 ~gIkg was injected subcutaneously into the upper medial aspect of the right foreleg of each dog. The limb was then exercised with brisk passive flexion and extension movements of the elbow and shoulder joints for ten minutes, At the end of the exercise period, additional cardiovascular measurements were made and blood samples withdrawn (12 to 15 minutes after envenomation).
A group off our of the eIght dogs were then given intravenous heparin (Fisons Pty Ltd, Thornleigh, NSW) in a dose of 100 U /kg. The remaining group of four dogs were not treated with heparin. Additional cardiovascular measurements were recorded and blood samples withdrawn at 30 minutes and at 60 minutes after envenomation. The dogs were then sacrificed. Three dogs in each group were subjected to post-mortem examinations of the thoracic and peritoneal cavities.
The statistical significance of the changes in cardiovascular indices in each group of heparintreated and untreated dogs (control group) was determined with repeated measures analysis of variance while the difference between the two groups was analysed using Student's t test. All statistical analyses were performed with the computer statistical program, 'Epistat' (TL Gustafson, Richardson, Texas, USA). This study was approved by the hospital ethics committee.
RESULTS

H aematological
Thrombocytopenia was observed 12 to 15 minutes after subcutaneous envenomation in the dogs not treated with heparin. The average decrement was 53 ± 32% (mean ± SO). This was accompanied by prolongation of the prothrombin times and activated partial thromboplastin times beyond three and five minutes respectively and by marked reduction on the serum levels of fibrinogen. At subsequent blood sampling times, 30 and 60 minutes after envenomation, the platelet counts remained low in this group. The average reductions were 65 ± 17% and 65 ± 24% respectively. No recovery of prothrombin times, activated partial thromboplastin times or serum fibrinogen level was present at 30 or 60 minutes after envenomation.
Thrombocytopenia was also observed in the group of dogs envenomated subcutaneously and subsequently treated with heparin. In this group, the platelet count was depressed by 83 ± 5% (mean ± SO) 12 to 15 minutes after envenomation. This was accompanied by prolongation of prothrombin times and activated partial thromboplastin times beyond three and five minutes respectively and by depression of serum fibrinogen levels below 20 Ilgldl in all dogs. Heparin was administered after these observations. At the next sampling times, 30 and 60 minutes after envenomation, prothrombin time and activated partial thromboplastin times remained prolonged and the serum fibrinogen levels very low. However, the platelet count increased but remained depressed to be 58 ± 25% and 33 ± 20% of baseline counts at 30 and 60 minutes after envenomation.
The differences in the platelet counts at all sampling times in the heparin treated group were not significantly different (Student's t test) from those in the control group. Cross-linked fibrin degradation products were not elevated in either group of dogs at any sampling time. The haematological indices of each dog in the control group is presented in Table 1 and those of the heparin treated group in Table 2 .
Cardiovascular
In the control group of four control dogs (which did not receive heparin), the resting blood pressure was 112 ± 9 mmHg (mean ± SO), the heart rate 114 ± 6 beats/minute, the central venous pressure 1.5 ± 0.6 mmHg, the cardiac output 264 ± 10 ml/kglmin, the stroke volume 2.32 ± 0.05 mVkg and the peripheral vascular resistance 33.4 ± 2.3 dyn.sec/cm 5 /kg. Ouring the period of limb exercise after subcutaneous envenomation, blood pressure began to decline, reaching a nadir at 15 to 20 minutes after envenomation. Inversion of the T wave and elevation of the ST segment were observed on the electrocardiograph. Mean blood pressure 12 to 15 minutes after envenomation had fallen significantly (P < 0.05) to 56 ± 30 mmHg.
This was accompanied by increments in heart rate (125 ± 17 beats/min), central venous pressure (3.8 ± 1.3 mmHg) and peripheral vascular resistance (48.1 ± 15.9 dyn.sec/cm5/kg) and by significant decrements in cardiac output (84 ± 34 mllkg/min, P < 0.005) and stroke volume (0.75 ± 0.44 ml/kg, P < 0.005). At twenty minutes after envenomation in all dogs, blood pressure was recovering. At thirty minutes after envenomation the mean blood pressure was 81 ± 13 mmHg, and at sixty minutes after envenomation was 93 ± 14 mmHg. At the latter time, the cardiac output and stroke volume had increased from the nadir to be 131 ± 30 mllkg/min and 1.11 ± 0.38 mllkg respectively while the heart rate and central venous pressure had decreased to 115 ± 26 beats/min and 1.0 ± 0.8 mmHg respectively.
In the group of four dogs envenomated subcutaneously and then treated with intravenous heparin, the resting mean blood pressure was 109±11 mmHg, the heart rate 111±25 beats/min, the central venous pressure 1.5±0.6 mmHg, the cardiac output 225±70 mVkg, the stroke volume 2.01±0.17 mVkg and the peripheral vascular resistance 40.1±1O.4 dyn.sec/cm 5 /kg. Similar changes in the cardiovascular indices were observed in this group 15 to 25 minutes after envenomation as were observed in the control group. Blood pressure declined significantly (P< 0.01) to 38±12 mmHg and was accompanied by increments in heart rate (144±12 beats/min), central venous pressure (4.3±1.9 mmHg), and peripheral vascular resistance (57.5±31.3 dyn.sec/ cm 5 /kg) and by significant decrements in cardiac output (51.3±14 mVkglmin, P<0.05) and stroke volume (0.35±0.08 mllkg, P < 0.005). Improvement in cardiovascular performance commenced within 25 minutes after envenomation in all four dogs. At thirty minutes after envenomation the mean blood pressure was 78±21 mmHg and at sixty minutes the mean blood pressure was 92±10.0 mmHg. At sixty minutes after envenomation the cardiac output was 122.3±38 mlIkglmin, the heart rate 92±10 beats/ min, the stroke volume 0.85±0.39 mVkg and the central venous pressure 1.0±0.8 mmHg.
The absolute cardiovascular indices for both groups of dogs are presented in Figure 1 .
Post-mortem examinations
In all six dogs subjected to post-mortem examination, haemorrhage was identified within the lungs or mesentery or on the surfaces of the kidneys, liver or spleen. No free collections of blood were present in the thoracic or peritoneal cavities. The blood in major vessels was fluid-like while thrombus was present within the heart chambers in four dogs. In two dogs, one from each group, thrombus was present in the left ventricles and in these dogs there was no demonstrable communication between right and left atria or ventricles. In one other dog, thrombus was observed adherent to the tip of the central venous catheter.
DISCUSSION
The early onset of cardiovascular changes and coagulopathy suggest that venom injected subcutaneously into an exercising limb is rapidly absorbed into the circulation, possibly by way of lymphatic vessels.
Haematological investigations 12 to 15 minutes after envenomation revealed a coagulopathy consistent with disseminated intravascular coagulation. Thrombocytopenia was accompanied by prolongation of prothrombin and activated partial thromboplastin times and depletion of serum fibrinogen. In the dogs not treated with heparin, the coagulopathy remained unchanged over the ensuing 45 minutes. In the heparin-treated group of dogs, the prothrombin times and the activated partial thromboplastin (expectedly) remained prolonged and the serum fibrinogen remained low. The platelet counts in the heparintreated groups recovered to be near or within the normal range in all four dogs 45 minutes after heparin administration. However, the difference in platelet counts in the dogs treated with heparin and those not treated with heparin was not statistically significant.
It has been demonstrated that prior administration of heparin prevents thrombocytopenia and other indices of disseminated intravascular coagulation usually observed after intravenous administration of Pseudonaja prothrombin activator. I Thrombocytopenia, after envenomation, may be a consequence of activation of coagulation or due to an unknown factor which induces platelet aggregation. 5 In this study, the recovery of the platelet count while other indices of coagulopathy remain abnormal, may signify that heparin antagonises an unidentified platelet aggregating factor. It is known that heparin has no direct effect on prothrombin activator 6 and exerts its anticoagulant effect by potentiating the effect of antithrombin III which inhibits thrombin and other activated coagulation factors.
Cardiovascular depression was documented within 12 to 15 minutes after subcutaneous injection of Pseudonaja textilis venom in all dogs. The onset of tachycardia and decrease in blood pressure were observed during the ten-minute period of limb exercise after envenomation. Hypotension and tachycardia were accompanied by diminution in cardiac output and stroke volume and by increments in central venous pressure and peripheral vascular resistance. These changes are similar to those observed after intravenous injection of Pseudonaja venom. 7 Over the subsequent 45 minutes of observation and measurement, cardiovascular function recovered to attain near pre-envenomation status in both heparin-treated and untreated groups of dogs. These observations are consistent with transient myocardial dysfunction and may be the aetiology of transient hypotension occasionally observed in human envenomation by Pseudonaja species. 8 
• 1O
There was no difference in the rate or extent of recovery in the heparin-treated groups of dogs compared to the untreated dogs.
The occurrence of coagulopathy and cardiovascular depression pari passu suggests that the two phenomena are linked. This is supported by electrocardiographic evidence of myocardial ischaemia during the onset of hypotension and tachycardia soon after envenomation and by the post-mortem discovery of thrombi in the cardiac chambers of some dogs.
The subcutaneous injection of Pseudonaja textilis venom causes the rapid onset of cardiovascular depression and disseminated intravascular coagulation in the dog. Administration of heparin during established cardiovascular depression and coagulopathy is not associated with reversal of these abnormalities and cannot be recommended for the treatment of established effects of envenomation.
